Our results showed that restriction of the G2/M checkpoint by WEE1 inhibition resulted in disturbed proteostasis and UPR activation in ovarian cancer cells with TP53 mutations, which was mediated by the NF‐κB‐governed SASP. Here, TP53 is linked to ovarian cancer.